Skip to content

HOESELTPHARMA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HOESELTPHARMA

BE 0826.754.259
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€115,196
2024 · €122,260-€7,065
Equity
€1.3m
2024 · €1.1m+€115,196
Cash
€565,607
2024 · €716,094-€150,487
Balance sheet total
€1.8m
2024 · €2.0m-€217,062

Largest movements

2024 to 2025
Assets
  • Cash -€150,487

    down €150,487 (-21.0%), from €716,094 to €565,607

    mainly Other debts (-€307,465) and Debts after one year (-€32,872)

  • Tangible fixed assets -€83,303

    down €83,303 (-9.5%), from €873,167 to €789,864

    of which Plant, machinery and equipment: -€64,003

  • Receivables within one year +€20,106

    up €20,106 (+16.0%), from €125,722 to €145,828

    of which Trade receivables: +€20,699

Equity and liabilities
  • Other debts -€307,465

    down €307,465 (-78.9%), from €389,629 to €82,164

  • Reserves +€115,196

    up €115,196 (+13.6%), from €845,348 to €960,544

  • Debts after one year -€32,872

    down €32,872 (-11.1%), from €297,051 to €264,179

Income statement
  • Staff costs +€16,803

    up €16,803 (+8.3%), from €202,357 to €219,159

  • Gross operating margin -€14,164

    down €14,164 (-2.8%), from €511,748 to €497,584

  • Financial charges -€13,971

    down €13,971 (-38.5%), from €36,317 to €22,346

  • Financial income +€5,245

    up €5,245 (+1859.8%), from €282 to €5,527

  • Taxes -€5,158

    down €5,158 (-9.6%), from €53,684 to €48,526

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €122,260
Gross operating margin -€14,164
Staff costs -€16,803
Depreciation -€537
Other operating charges +€65
Financial income +€5,245
Financial charges +€13,971
Taxes +€5,158
Result 2025 €115,196

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€108,935
Investment -€8,887
Financing -€32,665
Cash 2024 €716,094
Net result for the year +€115,196
Depreciation +€92,190
Stocks and contracts -€5,286
Receivables within one year -€20,106
Deferred charges and accrued income +€8,664
Trade debts +€9,374
Tax, wage and social debts -€2,241
Other debts -€307,465
Accrued charges and deferred income +€739
Investment in fixed assets (net) -€8,887
Debts after one year -€32,872
Current portion of long-term debt +€207
Cash 2025 €565,607
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,972,165 €1,755,104 -€217,062 -11.0%
Fixed assets 21/28 €873,167 €789,864 -€83,303 -9.5%
Tangible fixed assets 22/27 €873,167 €789,864 -€83,303 -9.5%
Land and buildings 22 €203,315 €196,875 -€6,440 -3.2%
Plant, machinery and equipment 23 €610,237 €546,234 -€64,003 -10.5%
Furniture and vehicles 24 €59,615 €46,756 -€12,859 -21.6%
Current assets 29/58 €1,098,998 €965,239 -€133,759 -12.2%
Stocks and contracts in progress 3 €159,432 €164,718 +€5,286 +3.3%
Stocks 30/36 €159,432 €164,718 +€5,286 +3.3%
Amounts receivable within one year 40/41 €125,722 €145,828 +€20,106 +16.0%
Trade receivables 40 €116,838 €137,537 +€20,699 +17.7%
Other amounts receivable 41 €8,884 €8,291 -€593 -6.7%
Current investments 50/53 €80,000 €80,000 = 0.0%
Cash at bank and in hand 54/58 €716,094 €565,607 -€150,487 -21.0%
Deferred charges and accrued income 490/1 €17,751 €9,086 -€8,664 -48.8%
Total equity and liabilities 10/49 €1,972,165 €1,755,104 -€217,062 -11.0%
Equity 10/15 €1,145,348 €1,260,544 +€115,196 +10.1%
Contributions 10/11 €300,000 €300,000 = 0.0%
Reserves 13 €845,348 €960,544 +€115,196 +13.6%
Distributable reserves 133 €845,348 €960,544 +€115,196 +13.6%
Amounts payable 17/49 €826,817 €494,560 -€332,257 -40.2%
Amounts payable after more than one year 17 €297,051 €264,179 -€32,872 -11.1%
Financial debts 170/4 €297,051 €264,179 -€32,872 -11.1%
Amounts payable within one year 42/48 €529,767 €229,642 -€300,125 -56.7%
Current portion of amounts payable after more than one year 42 €32,665 €32,872 +€207 +0.6%
Trade debts 44 €70,762 €80,136 +€9,374 +13.2%
Suppliers 440/4 €70,762 €80,136 +€9,374 +13.2%
Taxes, remuneration and social security 45 €36,711 €34,470 -€2,241 -6.1%
Taxes 450/3 €10,546 €6,679 -€3,867 -36.7%
Remuneration and social security 454/9 €26,165 €27,791 +€1,626 +6.2%
Other amounts payable 47/48 €389,629 €82,164 -€307,465 -78.9%
Accrued charges and deferred income 492/3 - €739 +€739
Non-recurring operating income 76A €4,545 - -€4,545
Remuneration, social security and pensions 62 €202,357 €219,159 +€16,803 +8.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €91,652 €92,190 +€537 +0.6%
Other operating charges 640/8 €5,759 €5,694 -€65 -1.1%
Gross operating margin 9900 €511,748 €497,584 -€14,164 -2.8%
Operating profit (loss) 9901 €211,979 €180,540 -€31,439 -14.8%
Financial income 75/76B €282 €5,527 +€5,245 +1859.8%
Recurring financial income 75 €282 €5,527 +€5,245 +1859.8%
Financial charges 65/66B €36,317 €22,346 -€13,971 -38.5%
Recurring financial charges 65 €36,317 €22,346 -€13,971 -38.5%
Profit (loss) for the period before taxes 9903 €175,944 €163,721 -€12,223 -6.9%
Income taxes 67/77 €53,684 €48,526 -€5,158 -9.6%
Profit (loss) for the period 9904 €122,260 €115,196 -€7,065 -5.8%
Profit (loss) for the period to be appropriated 9905 €122,260 €115,196 -€7,065 -5.8%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.